Full-Time

Senior Solution Architect

Posted on 8/23/2024

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Senior

Chicago, IL, USA

Hybrid position requiring in-office presence.

Category
Solution Engineering
Sales & Solution Engineering
Required Skills
Python
Data Science
R
Requirements
  • Advanced degree (Masters or PhD) in bioinformatics, computational biology, statistics, computer science, or related field, or 3+ years experience working with genomic and clinical data
  • Experience working with statistical modeling, data mining and/or machine learning methods
  • Proficiency in R or python and/or other programming languages
  • Strong project management and post-sales skills: understanding and qualifying customer requirements, supporting customers in making progress against a roadmap, aligning scientific results with business outcomes
  • Demonstrated ability to communicate technical concepts to non-technical stakeholders
Responsibilities
  • As a solution architect on the Lens team at Tempus, you’ll be on the front lines of our collaborations with external partners, helping guide customers through using the Lens platform to apply cutting-edge data science techniques to unique cancer datasets.
  • You will be engaged with customers throughout their time working with Lens, including training and onboarding, filtering for data of interest, and design and implementation of customer data science and analytical use cases.
  • Our solution architects should be comfortable on a whiteboard designing a pilot or in a board room with an Executive, providing trusted technical advice for our partners and clients.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where they have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Unlike many competitors, Tempus combines extensive research with practical applications in patient care and drug development. The goal of Tempus is to improve healthcare delivery and outcomes by leveraging advanced data analysis and AI.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
  • Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
  • Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

What critics are saying

  • Competition from partners like Genialis may lead to conflicts of interest.
  • Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
  • Technical challenges may arise in integration with Flatiron's OncoEMR platform.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids in personalized treatment decisions for cancer patients.
  • Tempus collaborates with biotech firms to enhance drug development using real-world data.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

INACTIVE